Associated Papers
Variant-specific functional effects of CTNNA1 in a humanized Drosophila model.
Lobo S et al.
European Journal of Human Genetics : Ejhg, 2026
Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.
Lobo S et al.
Gut, 2025
A protocol for karyotyping and genetic editing of induced pluripotent stem cells with homology-directed repair mediated CRISPR/Cas9.
Lobo S et al.
Biology Methods & Protocols, 2025
First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants.
Coudert M et al.
Journal of Medical Genetics, 2022
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA et al.
Acta Neuropathologica Communications, 2020
33087175 (PubMed )
Supplement: 40478_2020_1040_MOESM1_ESM.xlsx › Sheet1
Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer.
Clark DF et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2020
Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.
Benusiglio PR et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019
Select a paper to view details